CAPES Suicide Prevention @CAPESuicidePrev Dr. Dave Jobes with @CAMScare_tweets mentioned Jaspr Health in this discussion today. Jaspr makes use of time where patients would be waiting for care in the ED. Jaspr provides support with making a safety plan and a host of coping skills videos and shared stories. 8/28/24, 3:28 PM Joseph Thornton
Monthly Archives: August 2024
Post by EASO on X Infograph obesity facts
EASO @EASOobesity Obesity: The Hard Facts 23% of adults were estimated to have obesity in the EU in 2016. Obesity is the No.1 independent cause of premature mortality. 10-13% of deaths in parts of Europe are linked to obesity. Treat obesity the same way as other NCDs. easo.org/policy/ pic.twitter.com/zwBH4V1WuK 8/28/24, 2:32 AM Joseph Thornton
Post by JAMA Psychiatry on X. Boaters psychosis in dementia
JAMA Psychiatry @JAMAPsych Plasma levels of p-tau181 and NfL may be used as a biomarker for psychosis in mild cognitive impairment and Alzheimer disease, with potential implications for disease monitoring and treatment strategies. ja.ma/46A3Oz1 8/27/24, 6:00 AM Joseph Thornton
Post by Norman Fixel Institute for Neurological Diseases on X
Norman Fixel Institute for Neurological Diseases @FixelInstitute New research from Fixel and UF Health reveals a promising link between GLP-1 receptor agonists and a reduced risk of Parkinson’s in older adults with type 2 diabetes. The study found a 23% lower risk of PD among GLP-1RA users compared to DPP4i users. 🔗: …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md… pic.twitter.com/ymXGUgCv5v 8/27/24,Continue reading “Post by Norman Fixel Institute for Neurological Diseases on X”
Post by Michael Okun on X. GLP 1 prevent Parkinson’s
Michael Okun @MichaelOkun Do glucagon-like peptide-1 receptor agonists (GLP-1’s) reduce the risk of later Parkinson’s disease in type 2 diabetes? Tang and colleagues @FixelInstitute @UFPharmacy take apart this question in a new paper published in the @MDJ_Journal. Do you know where the term ‘let the cat… pic.twitter.com/sznpogiqIX 8/27/24, 8:50 AM Joseph Thornton
Post by deprescribing.org. Evidenced based tools for individualized care
deprescribing.org @deprescribing @AmyTPage @KennyPharmPhD @drhurwitz87 @DeprescribeAU Check out our evidence-based tools that can guide patient-specific #Deprescribing interventions! buff.ly/48I6Ph9 8/24/24, 12:00 PM Joseph Thornton
Semaglutide in Psychiatry—Opportunities and Challenges | Diabetes | JAMA Psychiatry | JAMA Network
Post by JAMA on infographic obesity rx
JAMA @JAMA_current Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medications in conjunction with lifestyle modification according to their mechanism of action. ja.ma/3MgehWZ pic.twitter.com/xPYwYE7clS 8/24/24, 8:00 AM Joseph Thornton
Post by Awais Aftab on diagnostic frameworks with Allen Frances
Awais Aftab @awaisaftab Psychiatric Diagnosis: A Clinical Guide to Navigating Diagnostic Pluralism New publication by me, @Castalia1981, @MarkLRuffalo, & @AllenFrancesMD! Focus is on helping clinicians navigate the current plurality of diagnostic frameworks (pdf 🔗in posts 👇) journals.lww.com/jonmd/abstract… pic.twitter.com/HFvmh9OHaS 7/30/24, 3:38 PM Joseph Thornton
Post by The Lancet on X. Suicide prevention
The Lancet @TheLancet This #WorldSuicidePreventionDay, attend a webinar about a new Lancet Public Health Series. Register free to hear the data and expert recommendations: hubs.li/Q02LpyM40 📌 In partnership with the International Association for Suicide Prevention (@IASPinfo) pic.twitter.com/oRHVgQIbUb 8/22/24, 12:07 PM Joseph Thornton
Gator Psychiatry 